Literature DB >> 20539231

Podocytes, glucose and insulin.

Gavin I Welsh1, Richard J M Coward.   

Abstract

PURPOSE OF REVIEW: In the last decade the importance of the podocyte in maintaining the integrity of the glomerular filtration barrier and prevention of albuminuria has become obvious. The leading cause of renal failure in the developed world is diabetic nephropathy. This has a defined natural history of progressive albuminuria. The two fundamental cellular changes that occur in diabetes mellitus are a failure of insulin to signal to cells and an environment of hyperglycaemia. The emerging role of these factors on the biological function of the podocyte will be reviewed. RECENT
FINDINGS: Hyperglycaemia causes both deleterious and protective cellular pathways to be initiated in the podocyte, which communicate with other cell types in the glomerulus. Furthermore, the podocyte is an insulin-sensitive cell which can be directly modulated by factors that increase and decrease its sensitivity to insulin.
SUMMARY: Our understanding of the cellular processes that affect the podocyte in diabetes and insulin resistance has progressed greatly in recent years and hopefully will result in new treatment strategies against the leading cause of renal failure in the developed world.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20539231     DOI: 10.1097/MNH.0b013e32833ad5e4

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  10 in total

1.  Increased urinary podocytes following indomethacin suggests drug-induced glomerular injury.

Authors:  Alison L Kent; Linda Brown; Margaret Broom; Amy Broomfield; Jane E Dahlstrom
Journal:  Pediatr Nephrol       Date:  2012-03-14       Impact factor: 3.714

Review 2.  Podocyte biology for the bedside.

Authors:  J Ashley Jefferson; Charles E Alpers; Stuart J Shankland
Journal:  Am J Kidney Dis       Date:  2011-06-29       Impact factor: 8.860

3.  Tracing the footsteps of glomerular insulin signaling in diabetic kidney disease.

Authors:  Gene-Yuan Chang; Ae Seo Deok Park; Katalin Susztak
Journal:  Kidney Int       Date:  2011-04       Impact factor: 10.612

4.  Physical Activity in the Prevention of Chronic Kidney Disease.

Authors:  Craig S Stump
Journal:  Cardiorenal Med       Date:  2011-07-25       Impact factor: 2.041

5.  Representing kidney development using the gene ontology.

Authors:  Yasmin Alam-Faruque; David P Hill; Emily C Dimmer; Midori A Harris; Rebecca E Foulger; Susan Tweedie; Helen Attrill; Douglas G Howe; Stephen Randall Thomas; Duncan Davidson; Adrian S Woolf; Judith A Blake; Christopher J Mungall; Claire O'Donovan; Rolf Apweiler; Rachael P Huntley
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

6.  Tangzhiqing Granules Alleviate Podocyte Epithelial-Mesenchymal Transition in Kidney of Diabetic Rats.

Authors:  Haiyan Xu; Xu Wang; Mingming Liu; Xueyuan He
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-10       Impact factor: 2.629

7.  PLK2 Plays an Essential Role in High D-Glucose-Induced Apoptosis, ROS Generation and Inflammation in Podocytes.

Authors:  Hong-Hong Zou; Ping-Ping Yang; Tian-Lun Huang; Xiao-Xu Zheng; Gao-Si Xu
Journal:  Sci Rep       Date:  2017-06-27       Impact factor: 4.379

Review 8.  Glucose Transporters in Diabetic Kidney Disease-Friends or Foes?

Authors:  Anita A Wasik; Sanna Lehtonen
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-09       Impact factor: 5.555

9.  Microalbuminuria as a simple predictor of incident diabetes over 8 years in the Korean Genome and Epidemiology Study (KoGES).

Authors:  Dong-Hyuk Jung; Young-Sup Byun; Yu-Jin Kwon; Gwang-Sil Kim
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

10.  Albuminuria according to status of autoimmunity and insulin sensitivity among youth with type 1 and type 2 diabetes.

Authors:  Amy K Mottl; Abigail Lauer; Dana Dabelea; David M Maahs; Ralph B D'Agostino; Larry M Dolan; Lisa K Gilliam; Jean M Lawrence; Beatriz Rodriguez; Santica M Marcovina; Giuseppina Imperatore; Roopa Kanakatti Shankar; Maryam Afkarian; Kristi Reynolds; Angela D Liese; Michael Mauer; Elizabeth J Mayer-Davis
Journal:  Diabetes Care       Date:  2013-07-11       Impact factor: 19.112

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.